BlackRock Advisors’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $239K | Sell |
2,871
-65
| -2% | -$5.41K | ﹤0.01% | 2566 |
|
|
2016
Q3 | $328K | Buy |
2,936
+186
| +7% | +$20.8K | ﹤0.01% | 2341 |
|
|
2016
Q2 | $305K | Sell |
2,750
-21
| -0.8% | -$2.33K | ﹤0.01% | 2352 |
|
|
2016
Q1 | $290K | Buy |
2,771
+201
| +8% | +$21K | ﹤0.01% | 2323 |
|
|
2015
Q4 | $207K | Sell |
2,570
-1,217
| -32% | -$98K | ﹤0.01% | 2509 |
|
|
2015
Q3 | $263K | Sell |
3,787
-72
| -2% | -$5K | ﹤0.01% | 2537 |
|
|
2015
Q2 | $378K | Buy |
3,859
+710
| +23% | +$69.5K | ﹤0.01% | 2348 |
|
|
2015
Q1 | $308K | Sell |
3,149
-5,346
| -63% | -$523K | ﹤0.01% | 2396 |
|
|
2014
Q4 | $936K | Sell |
8,495
-534
| -6% | -$58.8K | ﹤0.01% | 1510 |
|
|
2014
Q3 | $1.07M | Buy |
9,029
+6,110
| +209% | +$722K | ﹤0.01% | 1365 |
|
|
2014
Q2 | $379K | Buy |
2,919
+2,204
| +308% | +$286K | ﹤0.01% | 2182 |
|
|
2014
Q1 | $114K | Buy |
715
+87
| +14% | +$13.9K | ﹤0.01% | 2949 |
|
|
2013
Q4 | $87K | Buy |
628
+48
| +8% | +$6.65K | ﹤0.01% | 3078 |
|
|
2013
Q3 | $58K | Buy |
580
+243
| +72% | +$24.3K | ﹤0.01% | 3135 |
|
|
2013
Q2 | $13K | Buy |
+337
| New | +$13K | ﹤0.01% | 3343 |
|